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Abstract 
Studies reveal that viruses play important roles in the origins of cellular life and 
the evolution of all mammals for example. COVID-19 as a modified brutal 
virus has affected daily life and is slowing down the global economy. This 
pandemic has killed thousands of sick or infected people, Therefore, the main 
purpose of the current study stems from the question that how COVID-19 was 
created and how it will be solved. To conduct the present research, 26 English 
articles were chosen from among 57 articles published from 2000 to 2020 
based on their relation to viral diseases and the availability of the full text in 
PubMed, Science Direct, ProQuest, and Google Scholar databases. To study 
the new coronavirus, its genetic sequence should be accessible for us. As 
understood, synthetic biology takes advantage of the knowledge obtained from 
systems biology analysis and the conceptual tools made for such purposes. 
Computational modeling is an amalgam of systems and synthetic biology. 
These approaches develop systems toxicology as well as stand out in predicting 
and evaluating the immunogenicity of vaccines as well as improving vaccine 
formulations through a definite immunological marker. Due to acrimonious 
and costly episodes of human life and viral diseases such as SARS, MERS, and 
COVID-19, human beings need national security that can be provided by 
restoring health care services and educating more health care professionals is 
more effective than training the military. Dealing with such an issue demands 
vast knowledge of biotechnology, cell, and molecular biology expertise, and 
competent approaches based on bioinformatics technology that contains 
systems biology and synthetic biology. Therefore, such scientific fields need to 
be highly developed in developing countries to keep their immunity and 
national security under warranty encountering any biological invasion, most 
specifically of viral types. 
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Introduction 
Life on the earth includes a multitude of cellular 
organisms, and cellular life is immersed into an ocean 
of viruses each of which can enforce cellular organisms 
to fulfill their particular needs. There are around 100 
strains of the cold virus and the toxin they are often 
treated for. It takes us nearly 50 years to go through all 
the reformed cold viruses. Therefore, various have 
been here with us for ages. Studies reveal that viruses 
play important roles in the origins of cellular life and 
the evolution of all mammals for example. There is no 
doubt that we unconsciously discount or even pass over 
the viruses, due to their simplicity and intimate nature, 
to find out the evolutionary phenomenon of the living 
things.  
Yet, there are things that we are unknown of 
simple viruses or their roles in evolutionary processes. 
Our bodies and species often face ongoing fights with 
diseases. On the other hand, we have an immune 
system that can protect against such invasive diseases, 
but when an invader evolves a mechanism to surround 
the human immune system, it can infect people 
anywhere. Evolution to evade human immune defense 
explains why viruses that make colds spread through 
human populations readily (1, 2). 
The emergence of new virus diseases that often 
receives worldwide attention from scientists, 
researchers, and the lay public is one of the most 
moving prospects of virology. There has been 
mounting interest in the increasing number of viruses 
leading to unexpected illness and epidemics among 
humans, wildlife, and for more than two decades.  
The Emerging disease is most frequently used 
to refer to an unknown kind of infection or any other 
pathogenically changing infection that was already 
identified and has recently entered any new ecology or 
geographical environment. Noteworthy is that these 
diseases reveal some constantly evolving infections 
reacting to sudden changes in the relationship between 
the microbe and the body (3,4). 
COVID-19 (Coronavirus disease 2019) as a 
modified brutal virus has affected daily life and is 
slowing down the global economy. This pandemic has 
killed thousands of sick or infected people. Due to the 
high transferability of the virus among people, it is 
crucial to diagnose the disease at the early stages to 
curb its spread. Most countries have reduced their 
manufacturing of the products (5). 
Concerns over coronavirus being a bioweapon 
flourished due to its pandemic’s effect on the world is 
not a conventional form. It seems to be an extensive 
and indiscriminate attack on global citizens and the 
economy, which has directly influenced the lives of 
billions of people. This spread has shown itself as the 
most effective pattern for future terrorist activities and 
a new model for circumventing the properties of 
modern warfare (6). Therefore, the main purpose of the 
current study stems from the question that how 
COVID-19 was created and how it will be solved. 
 
Study Method 
To conduct the present research, the articles published 
between 2000 and 2020 were studied. To access the 
related scientific documentation, an electronic search 
was carried out using keywords such as COVID-19 and 
Coronavirus, separately or in combination with 
systems biology, synthetic biology, systems medicine, 
and vaccine in PubMed, Science Direct, ProQuest, and 
Google Scholar databases. Considering the 
aforementioned keywords, 57 related articles were 
found and 26 papers were used to serve the purpose of 
the current study after the initial research. The articles 
for review were chosen based on their relation to viral 
diseases, published between 2000-2020 in English, and 
the availability of the full text.  
However, other pieces of research presented at 
conferences, written in Persian, available as an 
abstract, or published on various websites were 
excluded. Having found the related articles, the 
researchers checked different parts including the topic, 
abstract, method, results, discussion, and references.  
 
Background  
Bioterrorism affects our lives and economy and that is 
why Terrorist Organizations try to weaken a target 
economy by applying a series of undemanding 
technologies in organized and complicated attacks on 
infrastructures. These attacks often include shootings, 
explosives, or even biochemical weapons like mustard 
gas.  
Designing and distributing these deadly 
biological weapons could be quite complex depending 
on the biological agent in question, for example, 
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Bacillus anthracis, an outstandingly multi-purpose and 
deadly pathogenic bacterium that leads to anthrax, 
usually takes place in any environment and infect 
almost all the living things.  
Anthrax is highly and easily transmittable and 
its extremely infectious spores get into the body by 
inhalation of aerosols or ingestion through polluted 
water supplies. As a result, anthrax is known as a major 
potential bioweapon. In 2001, five people in the United 
States died after receiving a mail polluted by anthrax 
but no one was ever arrested or charged (6-9). 
The important point is that a group of cold 
viruses has developed in a way that exchanges genetic 
information and constantly creates new viruses. There 
are approximately 100 types of cold viruses, and any 
person catches a cold almost twice a year (1). 
In contrast, applying synthetic biology to devise 
new bioweapons from earlier pathogens using CRISPR 
or DNA synthesis is far more complex in terms of 
laboratory requirements and expertise. Moreover, 
operating and managing these agents are more 
available by biotechnology companies competing 
aggressively to take the attention of academic, 
corporate, and government findings. 
Researchers have also equipped their 
laboratories with 3D-printed equipment that made 
complex instruments, once expensive and inaccessible, 
easily available to anyone interested in biotechnology.  
This approves the labor-saving development of 
weapons to take place anywhere from strict, regulated 
laboratories to remote facilities and even in one’s 
garage. Therefore, the accessible and easily used 
technologies enable any investor anywhere to consider 
and apply an underground bioweapon program. Talent 
is the only necessity that fills the gap.  
Also, terrorist organizations try to own the same 
infrastructural and scientific capabilities as modern 
industrial nations qualifying them to potentially 
generate biochemical supplies.  
The infrastructure requirements for biological 
weapons programs are also made easier since they are 
cheaper and more versatile in comparison to the 
nuclear arsenal. This is almost because they can be 
covered by any improvement in the medical industry, 
health, and agricultural research (9).  
It is worth mentioning that various theories 
concerning the nature of the recent coronavirus SARS-
CoV-2 have occupied the internet during the past few 
months. They often bring about more engrossing 
discussions than the ones implied by the authors; for 
 
Figure 1. In-silico biology and its sub-branches. 
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instance, the theory behind the new coronavirus, as an 
intentionally made biological weapon, displays that 
SARS-CoV-2 is exactly a synthetic organism, which in 
turn suggests that scientists can formulate man-made 
viruses.  
 
How far can modern technologies proceed 
considering the synthetic microorganisms’ 
paradigm? 
The recent state of synthetic biology is all we need to 
understand as a field with all the limitations it has if we 
ever want to answer these questions. Synthetic biology 
is highly dependent on prognostic patterns and 
computer-based formations. Computer programs use 
the information gathered through years of research 
about molecular biology, stored in equipped libraries 
of microorganisms, molecules, and domains, to 
examine their properties when reformed or 
combined in silico –done by a computer. These plans 
often form combinations that reasonably are not found 
in nature, so it is hard to analyze their potential 
structures for various purposes. Although in-silico 
models give us useful information and save our time 
and cost in vitro experimentations, they still seem to be 
imperfect (10, 11).  
Davies, a professor from the University of 
Edinburgh, published a paper in the open-access 
journal of Life and analyzed the recent stream of the 
‘engineering approach’ in synthetic biology. While 
working, he recognized that this approach is interesting 
for its design-build-test doctrine and that based on the 
standard existent parts that simplify the general pattern 
of fabricated structures, it lacks biological 
understanding. 
Any element of a microorganism has a 
metabolic cost in biology implying that the more 
constituent you add, the less energy the cell leads to 
other segments, so the fewer parts for its function, the 
better. Besides, it is assumed that when new genes are 
provided, the old genes are removed so that the 
organism remains usable and it is very important to 
notice in genetic engineering. 
Moreover, the true function of the genes is 
influenced by the interaction of the parts that existed 
before. Therefore, as Davies mentions, using a new 
component, devised for a specific purpose, is much 
easier than striving to stimulate a similar function with 
the parts that existed before. Finally, it can be pointed 
out that evolution does not rely on the combination of 
constant structures but depends on the continuous 
modifications of the pre-existing patterns affected by 
many items. Ultimately, synthetic biology, as a resort 
for unexplored and unknown phenomena, is not 
comparable with natural evolution in terms of 
completeness (12). 
It is worthy to mention that series of notions, 
devices, and approaches that alter or create biological 
organisms within biotechnology define synthetic 
biology. Although there is not a single definition for 
synthetic biology (different studies report specific and 
general usages), it is mentioned that synthetic biology 
“aims to improve the process of genetic engineering”. 
 
Figure 2. Biotechnology and Systems biology. 
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Notably, synthetic biology focuses on the Design-
Build-Test (DBT) cycle2, the frequent process of 
contriving a paradigm, fabricating a physically 
tangible example, evaluating the potentiality of the 
functionality of the paradigm, and learning from its 
imperfection during the progression of genetic 
engineering while applying the data to creating an 
upgraded design. Likewise, biological engineers can 
easily duplicate the DBT cycle to improve the design 
and the outcome for specific purposes by adopting 
modern computer technology, equipped laboratories, 
DNA synthesis, and sequencing technologies cost-
effective, and other effective methods for DNA 
maneuverings.  
The age of synthetic biology is initiated in both 
modern technologies and using the engineering 
patterns in biological fields. The idea of managing 
biological systems and adopting the engineering 
models from other disciplines dates back to the 
introduction of recombinant DNA technologies during 
the 1970s. Recently, there has been a cooperative 
attempt to manipulate both genetic matter and 
biological organisms.  
With this in mind, the potential of some specific 
technologies that enable biological materials to benefit 
from engineering paradigms has been escalated. To 
recognize the possible security opportunities and 
liability, evaluating novel technologies and policies 
that lead to inventive or damaging operation of 
biological matters, structures, and organisms. Several 
technologies have paved the way, facilitated the 
experimentations, especially in the DBT cycle, and 
qualified synthetic biology. What almost explains the 
recent changes in synthetic biology is the development 
of the mentioned technologies specifically devised for 
synthetic biology or general molecular biology and 
biotechnology manipulated by synthetic biologists. 
Such technologies are in fact instruments that provide 
the requirements of biological paradigms and 
structures. Some noticeable enabling technology fields 
involve DNA synthesis and assembly; Genome 
engineering; Improved computational modeling; 
Genetic logic; and Directed evolution. Biotechnology, 
a term used for almost one century, includes the use of 
biological elements or procedures to serve human 
goals; however, researchers have used its different 
forms to refer to millennia (13).  
Modern biotechnology projects require 
gathering, storing, classifying, analyzing, and 
distributing biological information provided by 
genomics projects. Likewise, different ways of saving, 
regaining and analyzing biological data and protein 
sequence, content, performances, pathways, and 
networks, in-silico disease simulation using the system 
biology recently are the focus of bioinformatics. 
Bioinformatics includes conceptual and practical 
instruments for spreading, creating, processing, and 
understanding scientific views and biological input. 
Thus, synthetic biology tries to facilitate and anticipate 
the functions of biology engineering (11,14).  
It is also important to consider how capable 
recent scientific methods are regarding virus 
engineering. Researchers can recreate a virus to make 
it more remarkable as it starts to expand like the 
coronavirus. Nevertheless, it is possible to create a new 
virus that demands another procedure like recreating a 
new virus from the original one, which is restricted 
from different perspectives (10,12).  
Synthetic biology demands the use of pre-
existing constituents meaning that it requires the use of 
various components of present viruses and their 
combination to create a new virus (10-13).  
Hence, creating a new virus at present is 
technically hypothetical requiring an unbelievable 
level of knowledge in any scientific institution. 
Nonetheless, our recent understanding of molecular 
science enables us to recognize the potential man-made 
structures or microorganisms since they are based on 
existent constituents; an engineered virus probably has 
identifiable DNA elements of other viruses whose 
successions are available in libraries. In other words, 
what we need to understand is making out whether a 
new virus is synthetic or naturally modified (10). 
To study the new coronavirus, its genetic 
sequence should be accessible for us. This has been 
notable progress in epidemiology, as pandemics 
researchers needed to wait for months and years 
previously to study the microorganism that caused the 
spread, while the formation of SARS-CoV-2 was 
recognized in less than a month. Having examined and 
analyzed the genetic structure, scientists have realized 
that this virus is a new one (10). We are aware that the 
backbone was not duplicated from a pre-existing virus 
but it can be artificially made.  
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What about modifying a pre-existing virus to 
mutate? That is to say, we can observe many cases in 
nature where biotechnologists mutate an existent virus 
to generate a new one. With this in mind, it was found 
out that as scientists assessed the SARS-CoV-2 
formation and juxtaposed it with other viral 
formations, approximately, 96 percent similarity was 
found between SARS-CoV RaTG13 and the new 
Coronavirus. Having the size of SARS-CoV-2 in mind, 
this number is significantly high since it is close to 
30,000 nucleotides long, around 1,200 nucleotides (10-
14). 
However, some may resist rejecting certain 
theories (10). A persuasive argument is that when some 
known segments of the same viruses are used, 
purposeful modifications have been probably applied 
to enable the virus to stick to humans and more 
specifically infect humans. One of the most astonishing 
facts about the coronavirus is that the receptor-binding 
domain – the part that enables SARS-CoV-2 to stick to 
human cells – was simulated in silico when the 
sequence of the virus was accessible. Such orders with 
insufficient capability for the simulations revealed that 
nature has an unpredictable mechanism.  
The epidemiologists and synthetic biologists, 
who are inspired by the process of molecular 
interactions, both benefit from studying the evolution 
of viruses. This can enhance the recent paradigms and 
pave the way for presenting new frameworks and 
producing new molecules. Hence, we can claim that 
studying the evolution of viruses helps synthetic 
biology to develop and serve as a useful tool (9-13). 
SARS and MERS got more victims around the world 
than the COVID-19 pandemic did; however, this 
worldwide spread has already caused more casualties. 
What helps us deal with the complicated nature of the 
mentioned disease in biology is a systems biology 
approach that makes the virus and mechanisms of 
disease more tangible (15). 
 
Discussion 
What differentiates synthetic biology from systems 
biology is ‘Engineering’ or ‘Synthesis of innovative 
functions’. Therefore, systems biology demands a 
quantitative understanding of present biological 
systems, while synthetic biology considers the logical 
engineering of such systems.  
As understood, synthetic biology takes 
advantage of the knowledge obtained from systems 
biology analysis and the conceptual tools made for 
such purposes. Taking it to the extreme, synthetic 
biology is an engineering discipline that demands 
standard parts that can be improvised using 
bioinformatics and simulation techniques to create 
circuits that can be modified (16).  
Systems biology is an interdisciplinary field that 
studies the heterogeneous interplays and the shared 
functions of a cell or an organism. Technologically, 
synthetic biology merges engineering and biological 
science and enables the design and manipulation of a 
system to be used for certain applications. Synthetic 
biology and systems both have key roles in the current 
progress of microbial platforms for energy, matter, and 
ecological usages.  
Noteworthy to mention is that systems biology 
gives us the required insight to improve the synthetic 
biology instruments, which leads to easy application 
and understanding of biological system complications. 
Therefore, to study microbes and carry out complicated 
tasks like generating biofuels we need both systems 
and synthetic biology due to their considerable 
potential. Both of them focus on science and 
technology; however, the knowledge of systems 
biology leads to a better design for synthetic biology 
tools that provide better insights into systems biology 
(17). 
Systems biology has fostered noticeably as a 
discipline during the last decade and the new method 
of systems medicine has emerged as a duplicated 
expansion of systems biology.  
Systems medicine is characterized by the way it 
is applied to systems biology to understand, adjust, 
prevent, and improve the growing illnesses and 
pathologic processes in human health. Although 
systems biology and systems medicine often overlap, 
systems biology seeks a basic understanding of 
biological procedures and a complete paradigm of 
biologic systems, while systems medicine focuses on 
the main objective purpose and relevance of 
translational models that consider the diagnostic, 
predictive, and therapeutic applications. Given such 
findings, due to the complexities of biology and 
medicine, the biological and medical aspects of 
systems medicine should be evaluated more (18). 
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Precision medicine, as the primary goal of 
systems medicine, asserted that these types of medicine 
demanding to be predictive, preventative, and 
participatory are not obtained by an increasing 
evolution rather by the drastic transformation in the 
application of medicine (19).  
Moreover, systems medicine studies Medical 
cybernetics as a branch of cybernetics that includes a 
recent working plan for using systems and 
communication theory, connectionism, and decision 
theory in biomedical investigation and health-related 
issues. Medical cybernetics seeks to describe the 
biological dynamics quantitatively and it studies the 
intercostal web in human biology, medical decision 
making, and information processing structures in 
the living organism (19).  
The application of these new methods of 
systems biology and synthetic biology has assisted 
biological sciences, clinical medicine, and any related 
area. In this regard, Toxicology research has recently 
started to cooperate with a variety of computational 
and artificial biological approaches for evaluating the 
toxicological hazard of chemicals. Systems toxicology 
was first introduced to define the use of systems 
biology techniques in toxicological studies (20).  
Another term is synthetic biology that possibly 
changes the form of toxicology and reveals how 
scientific methods like biology, bioengineering, 
chemical and electrical engineering, and 
computational modeling are related. Computational 
modeling merges systems and synthetic biology. 
Recent improvements in systems and synthetic biology 
include the engineering of synthetic genetic circuits, 
gene promoters, proteins, and a variety of synthetic 
biomolecules (21). 
 
Systems biology in vaccine development 
Vaccination prevents and curbs diseases effectively. 
Various viruses eradicated or effectively curbed by 
following vaccination curriculum mostly cause fatal 
epidemics like diphtheria, poliomyelitis, smallpox, and 
measles. Significantly, systems biology is studied from 
two main viewpoints; namely, a top-down approach in 
which the probable transformations, found through 
trial and error, are predicted deductively and a bottom-
up approach that includes inductive clinical research. 
The reverse engineering approach, on the other 
hand, is used in hypothesizing the factors that affect 
the high-tech tools used to record the global picture 
related to specific biological instances. 
These systems biology approaches stand out in 
predicting and evaluating the immunogenicity of 
vaccines as well as improving vaccine formulations 
through a definite immunological marker (20, 21). 
Having carried out worldwide research through 
systems biology, we understand the complicated and 
interrelated interactions between the invulnerable 
performance of the host (immunotherapy) and the 
innately adaptive reactions.  
Useful knowledge in immunology and genetics 
can be provided by an inclusive analysis at the system 
level of immune reaction to vaccines and 
immunotherapies (vaccinomics or systems 
vaccinology). This, in turn, causes great progress in 
vaccine advancements like the identification of optimal 
antigens, and antigen formulations (i.e. adjuvant 
antigens), and influencing the searched cluster of genes 
and immune tracks that provide the essential adaptive 
immune reaction. 
Besides, it facilitates screening for reactions to 
vaccines or immunotherapies and perceiving ultimate 
collapse among individuals took part in clinical trials 
largely.  
In truth, the applicability of such inclusive 
analysis in epitomizing the treatment to get a better 
clinical result is remarkable when the recognition of 
gene records or polymorphic genes associated with 
immune reactions to immunological approaches are 
taken into account.  
Nonetheless, if vaccinology is going to be used 
as a worldwide system, systems biology should follow 
several procedures because this science is still 
improving. The broadness and complexity of the 
polymorphous nature of immune reaction genes 
necessitate several hi-tech and bioinformatics 
approaches to reasonably operate the extensive genetic 
data.  
Likewise, to categorize natural and immune 
response-related genetic - gene expression or 
polymorphism – modifications, it is vital to assess 
various studies carried out in wider circumstances with 
the different genetic backgrounds; although, few 
studies have revealed that genes are balanced facing 
vaccination causally. 
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The assessment of the output in definite 
contexts to merge numerous information types helps us 
to deal with such issues.  
Besides, based on the evaluation of vaccine or 
immunotherapy, the peripheral blood mononuclear 
cells do not always reflect the identification of the 
predictive target cell population.  
However, being used in vaccinology and free 
from cultural, technical, and financial concerns, 
systems biology shows the path to create new vaccines, 
renew earlier vaccines, and shift from the “empirical” 
to “knowledge-based” phase of vaccinology. This, in 
turn, causes the progress of more prosperous vaccines 
for human diseases with individual or group-
personalized strategies through both preventive and 
restorative intervention approaches (21). 
The synthetic biology approach can be 
potentially applied to the creation of vaccines to fight 
pathogenic viruses or bacteria (22). 
Nevertheless, making vaccines is implausibly 
demanding since the antigenic nature of viruses is 
highly diverse and high metamorphosis velocity does 
not succeed by applying primary vaccine 
manufacturing methods and the challenges, included in 
the processes that bring about serious restrictions. 
Virus-like particles (VLPs) are reproduced 
noninfectious viral structures that show the immune 
defensive quality of the original viruses. Some VLPs, 
comparable to any natural virus structurally, have been 
evolved and accredited as vaccines. Recently, a huge 
research surplus admits that for a safe display of 
heterologous antigens among several pathogens that 
are irrelevant to other selected carrier VLPs, it is vital 
to design VLPs. 
Such versatile designs help VLPs to 
technologically renovate vaccine supply and disease 
reaction using rational bioengineering. Such 
opportunities are highly improved by using synthetic 
biology, recreation, and the creation of innovative 
biological entities (23). 
Bluetongue appears to be one of the highly 
contagious diseases among ruminants caused by the 
bluetongue virus (BTV), an arbovirus available in 
nature in at least 26 different serotypes. In what 
follows, the improvement of a vaccine platform for 
BTV will be reported. 
Pathogen genomes, later used to manufacture 
vaccines, can be planned and generated safely and 
quickly due to the emergence of synthetic biology 
approaches as well as the progress of converse genetics 
systems.  
BTV vaccines are often described considering 
“synthetic” viruses that contain outer core proteins of 
various BTV serotypes integrated into a common 
tissue-culture adapted backbone. Having the recent 
industry experience in mind, the synthetic biology 
approach for vaccine development could save 6 
months across the entire vaccine pipeline (24).  
 
Conclusion 
The spread of SARS, MERS, and COVID-19 during 
the past two decades manifest the coincidence of 
vulnerable viruses and human society that has 
influenced human lifestyle until now. Due to 
acrimonious and costly episodes of human life and 
these viral diseases, human beings have felt the need 
for better rehabilitation of health care professionals 
than the military for gaining national security. 
Although there may not exist a conspiracy 
theory or the terrorist-like nature of the COVID-19 
virus, the symptoms of the tenacious Covid-1 signify 
that human societies’ greatest concern is not getting 
equipped with military weapons, particularly nuclear 
weapons, but is being enabled to encounter deadly 
viruses that have killed millions of people heartlessly.  
Overcoming such a big challenge needs cell and 
molecular biology expertise, biotechnology, and 
efficient methods based on bioinformatics technology 
that includes systems biology and synthetic biology. 
Such theoretical and practical sciences should aim at 
the Genetic metamorphosis of fatal viruses to save their 
risks and benefits. 
Developing countries, including Iran, must 
seriously foster the aforementioned sciences to 
guarantee their safety against any biological invasion, 
especially viral type. Moreover, by applying systems 
biology to medical sciences (i.e. Systems Medicine), 
and by planning an encyclopedic roadmap in this field, 
they should make prompt and effective strides to build 
up their health system (increase the quality of health 
care and development of medical technologies). 
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